Literature DB >> 26143642

Derivation and validation of an HbA1c optimal cutoff for diagnosing prediabetes in a South African mixed ancestry population.

Annalise E Zemlin1, Tandi E Matsha2, Andre P Kengne3, Rajiv T Erasmus4.   

Abstract

INTRODUCTION: Prediabetes compromises impaired fasting glucose and impaired glucose tolerance and is a high risk for future diabetes mellitus and cardiovascular disease. Traditional diagnostic methods involve a fasting sample or oral glucose tolerance test, which is cumbersome, time-consuming and inconvenient. An HbA1c-based approach has been incorporated into new guidelines, but cut-offs may vary and have not been defined for all population groups. We derived and validated HbA1c cut-offs to diagnose prediabetes in mixed ancestry South Africans.
METHODS: Participants were 667 (derivation sample), 234 (validation sample 1) and 674 (validation sample 2) diabetes-free individuals. They underwent standard 2-hour OGTT with HbA1c test. Receiver-operator characteristic curves were used to determine optimal HbA1c cut-off to predict prediabetes.
RESULTS: A total of 27.7% participants in the derivation sample had prediabetes versus 17.5% (validation sample 1) and 15.4% (validation sample 2). The optimal cut-off was 5.75% in all three cohorts with sensitivity and specificity of 64.8% and 60.4% in combined derivation and validation sample 1, and 59.6% and 69.8% in validation sample 2.
CONCLUSION: The discriminatory capacity of HbA1c for predicting prediabetes in this population is modest at the derived cut-off. The use of HbA1c alone in this setting may result in an inaccurate diagnosis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HbA1c; Optimal cut-off; Prediabetes; ROC curve

Mesh:

Substances:

Year:  2015        PMID: 26143642     DOI: 10.1016/j.cca.2015.06.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Characteristics of participants who take up screening tests for diabetes and lipid disorders: a systematic review.

Authors:  Hanyue Ding; Junjie Huang; Yunyang Deng; Sze Pui Pamela Tin; Martin Chi-Sang Wong; Eng-Kiong Yeoh
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

2.  Glycated nail proteins as a new biomarker in management of the South Kivu Congolese diabetics.

Authors:  Philippe B Katchunga; Patrick N Mirindi; Antoine S Kishabongo; Justin C Cikomola; Socrate Bwanamdogo; Jan Philippé; Marijn M Speeckaert; Joris R Delanghe
Journal:  Biochem Med (Zagreb)       Date:  2015-10-15       Impact factor: 2.313

3.  Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans.

Authors:  Kim A Nguyen; Nasheeta Peer; Anniza de Villiers; Barbara Mukasa; Tandi E Matsha; Edward J Mills; Andre P Kengne
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

4.  Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis.

Authors:  Gunjeet Kaur; P V M Lakshmi; Ashu Rastogi; Anil Bhansali; Sanjay Jain; Yot Teerawattananon; Henna Bano; Shankar Prinja
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.